期刊文献+

PTEN蛋白在垂体瘤中的表达及其意义 被引量:8

Expression of PTEN protein in pituitary tumor
暂未订购
导出
摘要 目的 :探讨垂体瘤中抑癌基因 pten编码产物的表达情况及临床病理意义。方法 :应用免疫组织化学技术检测 36例垂体肿瘤及 6例正常脑组织中 PTEN蛋白的表达情况。 结果 :对照组 6例正常脑组织 PTEN表达全部阳性 ,强阳性率为83.3% (5 / 6 ) ;2 8例非侵袭垂体瘤中 PTEN的阳性表达率为 78.5 % (2 2 / 2 8) ,强阳性率为 35 .7% (10 / 2 8) ,阳性信号存在于胞质中 ,与正常对照组比较强阳性率差异有统计学意义 (P<0 .0 5 ) ;而 8例侵袭性垂体瘤 (包括 1例垂体癌 )中 PTEN无强阳性表达 ,阳性率为 2 5 .0 % (2 / 8) ,与正常对照组及非侵袭性垂体瘤比较皆有显著性差异 (P<0 .0 1)。 结论 :垂体瘤的发生发展中存在 pten基因的失活现象 。 Objective:To investigate the protein expression of tumor suppressor gene pten in pituitary tumor.Methods:A total of 36 cases of pituitary tumor tissues and 6 cases of normal brain after brain trauma surgery were analyzed for PTEN protein expression by immunohistochemical method.Results:The strong positive rate was 83.3%(5/6) in normal brain and 35.7%(10/28) in 28 cases of non invasive pituitary tumor.There was significant difference between them in the pattern of PTEN protein expression( P <0.05).The positive rate was 100.0% in normal brain and 25.0%(2/8) in 8 cases of invasive pituitary tumor and pituitary carcinoma.There was significant difference between them in the pattern of PTEN protein expression( P <0.01).Conclusion:It is indicated that pten gene inactivation may play a role in the genesis and development of pituitary tumor.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第8期847-849,共3页 Academic Journal of Second Military Medical University
基金 国家自然科学基金 ( 3 9670 73 3 )
关键词 垂体瘤 PTEN蛋白 抑癌基因 pten编码产物 病理 免疫组织化学 pituitary tumor PTEN protein prognosis
  • 相关文献

参考文献8

  • 1Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997,15(4): 356-362.
  • 2Myers MP, Stolarov JP, Eng C, et al. P-TEN, the tumor suppressor from human chromosome 10q23,is a dual specificity phosphatase [J]. Proc Natl Acad Sci USA, 1997, 94(17):9052-9057.
  • 3Weng LP, Brown JL, Eng C. PTEN coordinates G1 arrest by down-regulating cyclin D1 via protein phosphatase activity and upregulating p27 via its lipid phosphatase activity in a breast cancer model[J]. Hum Mol Genet, 2001,10(6) : 599-604.
  • 4Pernicone PJ, Scheithauer BW, Sebo TJ,et al. Pituitary carcinoma : a clinicopathologic study of 15 cases[J]. Cancer, 1997,79(4) :804-812.
  • 5Bates AS, Farrell WE,Bicknell EJ ,et al. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker[J]. J Clin Endocrinol Metab, 1997,82(3) :818-824.
  • 6Levy A,Hall S,Yeudall WA,et al. p53 gene mutations in pituitary adenomas: rare events[J]. Clin Endocrinol ( Oxf ) , 1994,41(6):809-814.
  • 7Dahia PL,Aguiar RC, Honegger J,et al. Mutation and expression analysis of p27kip1 gene in corticotrophin-secreting tumours[J]. Oncogene, 1998,16(1) : 67-76.
  • 8Yoshimoto K, Tanaka C, Yamada S, et al. Infrequent mutations of p16INK4A and p15INK4B genes in human pituitary adenomas[J]. Eur J Endocrinol, 1997,136(1) : 74-80.

同被引文献75

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部